5 Item 1A. Risk Factors 37 Item 1B. Unresolved Staff Comments 95 Item 1C. Cybersecurity 95 Item 2. Properties 95 Item 3. Legal Proceedings 96 Item 4. Mine Safety Disclosures 96 PART II 97 Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 97 Item 6. [ Reserved ] 97 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 98 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 106 I...
Q2 FY2026 — expected 2026-08-14
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-12 | 2025-12-31 | 0001720580-26-000008 | EDGAR | 103K words |
| 2025-03-06 | 2024-12-31 | 0000950170-25-034587 | EDGAR | — |
| 2024-03-19 | 2023-12-31 | 0000950170-24-033482 | EDGAR | — |
| 2023-03-15 | 2022-12-31 | 0000950170-23-008130 | EDGAR | — |
| 2022-03-15 | 2021-12-31 | 0000950170-22-003753 | EDGAR | — |
| 2021-03-12 | 2020-12-31 | 0001564590-21-012664 | EDGAR | — |
| 2020-03-12 | 2019-12-31 | 0001564590-20-010474 | EDGAR | — |
| 2019-03-18 | 2018-12-31 | 0001564590-19-008262 | EDGAR | — |
| 2018-03-29 | 2017-12-31 | 0001564590-18-007150 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-05 | 2025-09-30 | 0001193125-25-266880 | EDGAR | 71K words |
| 2025-08-07 | 2025-06-30 | 0000950170-25-104978 | EDGAR | — |
| 2025-05-06 | 2025-03-31 | 0000950170-25-064448 | EDGAR | — |
| 2024-11-06 | 2024-09-30 | 0000950170-24-122253 | EDGAR | — |
| 2024-08-13 | 2024-06-30 | 0000950170-24-095745 | EDGAR | — |
| 2024-05-14 | 2024-03-31 | 0000950170-24-059507 | EDGAR | — |
| 2023-11-08 | 2023-09-30 | 0000950170-23-061128 | EDGAR | — |
| 2023-08-09 | 2023-06-30 | 0000950170-23-040631 | EDGAR | — |
| 2023-05-09 | 2023-03-31 | 0000950170-23-019700 | EDGAR | — |
| 2022-11-08 | 2022-09-30 | 0000950170-22-023230 | EDGAR | — |
| 2022-08-10 | 2022-06-30 | 0000950170-22-016254 | EDGAR | — |
| 2022-05-12 | 2022-03-31 | 0000950170-22-009690 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-12 | 0001720580-26-000006 | EDGAR | 2K words |
| 2026-01-07 | 0001193125-26-005486 | EDGAR | — |
| 2025-12-29 | 0001193125-25-332343 | EDGAR | — |
| 2025-12-19 | 0001193125-25-326784 | EDGAR | — |
| 2025-11-05 | 0001193125-25-266860 | EDGAR | — |
| 2025-10-07 | 0001193125-25-233427 | EDGAR | — |
| 2025-10-07 | 0001193125-25-232558 | EDGAR | — |
| 2025-10-07 | 0001193125-25-232539 | EDGAR | — |
| 2025-08-07 | 0000950170-25-104969 | EDGAR | — |
| 2025-07-23 | 0000950170-25-097881 | EDGAR | — |
209 total filings indexed. 178 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001720580 |
| Ticker | ACET |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.adicetbio.com |
| Listed | 2020-09-16 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report